Nykredit A/S’s Praxis Precision Medicines PRAX Stock Holding History

Nykredit A/S’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Buy	+779	New	+$247K	﹤0.01%	934

Other funds holding PRAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's PRAX Position: Q2 2026 in Review

Nykredit A/S opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 779 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #934 among its holdings.

188 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Nykredit A/S held 779 shares of Praxis Precision Medicines worth $261K as of Q2 2026.
Praxis Precision Medicines was a new Nykredit A/S position in Q2 2026.
Praxis Precision Medicines made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #934 holding.
188 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.